Researchers found that mRNA cancer vaccines can recruit an unexpected immune cell to launch powerful tumor-fighting responses ...

Researchers identified a six-gene signature in microscopic colorectal cancer (CRC) liver metastases that may help predict ...

Building on recent successes, scientists are focused on a promising new frontier: sending tiny particles into the body to ...

A study tracking more than 10,000 patients with early-stage, obesity-related cancers found that those taking GLP-1 receptor ...

On 1 June 2026, the European Commission published a communication setting out a roadmap to phase out animal testing for ...

Patients with triple-negative breast cancer who cannot receive immunotherapy now have a new first-line treatment option after ...

The global stem cell banking market is experiencing robust compound annual growth rate (CAGR) expansion, driven by escalating demand-side dynamics, rising awareness of regenerative medicine ...

The field of cancer genomics is rapidly evolving, driven by advanced technologies that enable detailed characterization of cancer initiation, progression, ...

Exelixis, Inc.'s STELLAR-303 zanzalintinib data disappoints in colorectal cancer with an FDA decision due in December 2026.

Bladder cancer continues to be one of the most frequently diagnosed malignancies worldwide, with current treatments such as surgery and chemotherapy often ...

A team at Roswell Park Comprehensive Cancer Center has identified a novel metabolic pathway that plays a key role in enabling ...